150 related articles for article (PubMed ID: 1782061)
21. Bone marrow micrometastases and adjuvant treatment of breast cancer.
Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow micrometastases in breast cancer patients.
Molino A; Pelosi G; Micciolo R; Turazza M; Nortilli R; Pavanel F; Cetto GL
Breast Cancer Res Treat; 1999 Nov; 58(2):123-30. PubMed ID: 10674876
[TBL] [Abstract][Full Text] [Related]
23. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
24. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
Cote RJ; Rosen PP; Lesser ML; Old LJ; Osborne MP
J Clin Oncol; 1991 Oct; 9(10):1749-56. PubMed ID: 1919627
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.
Coombes RC; Berger U; Mansi J; Redding H; Powles TJ; Neville AM; McKinna A; Nash AG; Gazet JC; Ford HT
NCI Monogr; 1986; (1):51-3. PubMed ID: 3774015
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
[TBL] [Abstract][Full Text] [Related]
28. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
29. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow micrometastases in breast cancer patients.
Simmons R; Hoda S; Osborne M
Am J Surg; 2000 Oct; 180(4):309-12. PubMed ID: 11113442
[TBL] [Abstract][Full Text] [Related]
32. Detection and management of bone marrow micrometastases in breast cancer.
Osborne MP; Rosen PP
Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
[TBL] [Abstract][Full Text] [Related]
33. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up.
Gebauer G; Fehm T; Merkle E; Beck EP; Lang N; Jäger W
J Clin Oncol; 2001 Aug; 19(16):3669-74. PubMed ID: 11504748
[TBL] [Abstract][Full Text] [Related]
34. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
35. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
Solomayer EF; Diel IJ; Salanti G; Hahn M; Gollan C; Schütz F; Bastert G
Clin Cancer Res; 2001 Dec; 7(12):4102-8. PubMed ID: 11751508
[TBL] [Abstract][Full Text] [Related]
36. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
Wu J; Yu Z; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I; Guller U; Worni M; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Viehl C; Bronz L; Schnarwyler B; Wight E; Infanger E; Burger D; Koechli OR; Zuber M;
Ann Surg Oncol; 2014 Feb; 21(2):401-7. PubMed ID: 24145993
[TBL] [Abstract][Full Text] [Related]
38. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Harbeck N; Untch M; Pache L; Eiermann W
Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
[TBL] [Abstract][Full Text] [Related]
39. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
[TBL] [Abstract][Full Text] [Related]
40. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
Susnik B; Frkovic-Grazio S; Bracko M
Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
